MedicarePartD.guide

A non-government resource built from CMS public data

Non-statin cholesterol drugs on Blue Shield Rx Enhanced (S2468-004)

Ezetimibe, the PCSK9 drugs Repatha and Praluent, and Nexletol, checked against this plan's 2026 formulary (its list of covered drugs).

Plan type
Stand-alone drug plan (PDP), California
Premium
$227.80/month
Deductible
None
Change plan

4 of 8 Non-statin cholesterol drugs are covered on this plan. 1 of them require prior authorization.

4 aren't on the formulary, including Praluent and Nexletol.

Not on the formulary
Praluent, Nexletol, Nexlizet, Vascepa

Patient cost for a 30-day supply at a preferred retail pharmacy. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.

Full plan details · This plan's whole drug list